JamesSGoydosMD
General Surgery • Philadelphia, PASurgical Oncology (Other than Breast)
American Association for Cancer Research (AACR); Clinical Cancer Research Journal
Dr. Goydos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
615 Chestnut Street 17th Floor |
Philadelphia, PA 19106Phone+1 215-440-9354- Is this information wrong?
Summary
- Dr. James S. Goydos is a general surgeon in New Brunswick, New Jersey and is affiliated with multiple hospitals in the area. He has been in practice for more than 20 years.
Clinical Expertise
- Skin cancer, Melanoma, Soft tissue cancer, Soft tissue sarcomas, Oncology, Surgical oncology (non-breast), Merkel cell carcinoma, Skin cancer surgery, Health education, Biochemistry
Education & Training
University of ConnecticutResidency, Surgery, 1988 - 1993
Rutgers Robert Wood Johnson Medical SchoolClass of 1988
Certifications & Licensure
NJ State Medical License 1995 - 2021
Awards, Honors, & Recognition
- ACS Fellow
- Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2014
- Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
- Join now to see all
Clinical Trials
- Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery Start of enrollment: 2007 Feb 01
- Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2009 Apr 01
Publications & Presentations
PubMed
- Prevention and early diagnosis of cutaneous melanoma.Goydos Js> ;New Jersey Medicine. 2000 May 1
- 11 citationsSentinel lymph node mapping in melanoma of the ear.Philip D. Wey, C De La Cruz, J S Goydos, M L Choi, G L Borah> ;Annals of Plastic Surgery. 1998 May 1
- 211 citationsA phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinomaJames S. Goydos, Elaine M. Elder, Theresa L. Whiteside, Olivera J. Finn, Michael T. Lotze> ;Journal of Surgical Research. 1996 Jun 1
- Join now to see all
Lectures
- Melanoma & Skin Cancer Patient & Caregiver SymposiumCancer Institute Of New Jersey Cinj - 5/16/2017
- Treatment of Locally and Regionally Advanced MelanomaRutgers Cancer Institute of New Jersey - 9/13/2014
Other
- Methods and Compositions for Treating Cancer; PatentJames S. Goydos, Suzie Chen, Current Assignee: Rutgers State University of New Jersey
https://patents.google.com/patent/US20100221246A1/en?inventor=James+S.+Goydos
4/6/2010 - Methods and Compositions for Treating Melanoma; PatentJames S. Goydos, Suzie Chen, Current Assignee: Rutgers State University of New Jersey
https://patents.google.com/patent/US7691377B2/en?inventor=James+S.+Goydos
4/6/2010 - Detection of Mutations in Nucleic Acid Sequences; PatentJames S. Goydos, Application filed by University Of Medicine And Dentistry Of New Jersey
https://patents.google.com/patent/WO2005006940A2/en?inventor=James+S.+Goydos
6/30/2005
Authored Content
- Can You Get a Sunburn in the Winter?December 2021
- Can You Get a Sunburn in the Winter?December 2021
- When Do Americans Get Their Freedom BackNovember 2021
- Melanoma Knows No SeasonNovember 2021
- The Importance of Breast Cancer AwarenessOctober 2021
- Rates of Skin Cancer in New Jersey Higher Than the National AverageSeptember 2021
- How Both The Mentor And The Mentee Help Each Other SucceedAugust 2021
- Humans Are Never Far From Chaos And BarbarismAugust 2021
- Everyday Ways to Give Back to the CommunityJuly 2021
- Any Competent Public Health Doctor Could Predict What Would Happen During The PandemicMay 2021
- Any Competent Public Health Doctor Could Predict What Would Happen During The PandemicMay 2021
- How a Trauma Death Can Turn Doctors into Better SurgeonsMay 2021
- How a Trauma Death Can Turn Doctors into Better SurgeonsMay 2021
- What Ever Happened to the Concept of the Absent-Minded Professor?April 2021
- What Ever Happened to the Concept of the Absent-Minded Professor?April 2021
- The Trolley Problem & The Pandemic: What Would You Choose?January 2021
- What You May Not Know About Breast CancerOctober 2020
- Coronavirus and Physician Burnout Are Adding Fuel to the FireOctober 2020
- Why ‘White Coat Syndrome’ and The Pandemic Are A Double ThreatOctober 2020
- Why Do We Still Use Fax Machines In Medicine?October 2020
- Join now to see all
Press Mentions
On Memorial Day, We Should Talk Skin Cancer in the MilitaryMay 28th, 2022- When Do Americans Get Their Freedom Back?September 14th, 2021
Biohaven Announces First Patient Treated in Clinical Research Collaboration At Rutgers Cancer InstituteMay 18th, 2020- Join now to see all
Grant Support
- Regulation of tumor released exosomes and glutamatergic signalingNational Cancer Institute2014–2017
- Combination Therapy that Targets Glutamate Signaling in MelanomaNational Cancer Institute2010–2015
- A Patient Oriented Research Program for Surgical OncologistsNational Cancer Institute2010–2015
- Validation of Grm1 as a Therapeutic Target in MelanomaNational Cancer Institute2007–2013
- A Phase II Trial of Riluzole in Patients with Advanced MelanomaNational Cancer Institute2009–2011
- A Phase 0 Trial of Riluzole in Patients with Resectable Stage III or IV MelanomaNational Cancer Institute2007–2008
Professional Memberships
- Editorial Board Member
Other Languages
- Spanish
External Links
- Publicationshttps://orcid.org/0000-0001-9811-939X
- LinkedInhttp://www.linkedin.com/in/jamesgoydos
- Websitehttps://www.jamesgoydos.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
